
Analyzing Akero Therapeutics Inc (AKRO) After Recent Trading Activity
In a filing, Akero Therapeutics Inc revealed its President and CEO Cheng Andrew unloaded Company’s shares for reported $2.04 million
In a filing, Akero Therapeutics Inc revealed its President and CEO Cheng Andrew unloaded Company’s shares for reported $2.04 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Akero Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Rolph Timothy unloaded Company’s shares for reported $1.38 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akero Therapeutics
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Akero Therapeutics Inc’s filing revealed that its Senior VP, Commercial Strategy Lamy Patrick unloaded Company’s shares for reported $0.2 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Akero Therapeutics Inc’s filing revealed that its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.39 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or